PJA1 and Alzheimer disease: Intriguingly, studies have reported a downregulation of PRAJA1 in Alzheimer’s disease (AD) models [20], raising the critical question of whether this dysregulation contributes to the synaptic and cognitive impairments characteristic of AD.